Roche Collaborates With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
Roche Collaborates With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
羅氏與PatHai合作擴展伴隨診斷的數字病理學能力
- PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
- The image analysis algorithms will be deployed on Roche's navify Digital Pathology platform, allowing seamless integration into pathology laboratories worldwide.
- The collaboration between RTD and PathAI helps advance precision medicine by bringing together AI-interpretation and companion diagnostics, increasing patient access to targeted treatments.
- PathaI將獨家與羅氏組織診斷（RTD）合作，爲RTD的伴隨診斷業務開發人工智能（AI）數字病理學算法。
- 圖像分析算法將部署在羅氏的navify數字病理學平台上，從而可以無縫集成到全球病理學實驗室中。
- RTD和PathaI之間的合作將人工智能解釋和伴隨診斷相結合，從而增加患者獲得靶向治療的機會，從而幫助推進精準醫療的發展。